Alfred E. Mottur, shareholder and managing partner of Brownstein Hyatt Farber Schreck’s Washington, D.C., office, was recently appointed to the Medical University of South Carolina’s Hollings Cancer Center Board of Directors. As a member of the board, Mottur will advise the Center in the areas of strategic planning, patient care, health policy, fundraising and development, and outreach initiatives. Additionally, he will assist in advocating on behalf of the Center in the areas of cancer prevention, care and research.
Hollings Cancer Center at the Medical University of South Carolina offers state-of-the-art diagnostic capabilities, therapies and surgical techniques, and has multidisciplinary clinics that involve surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and many other specialists seeing patients under one roof. Multidisciplinary care is provided in disease specific clinics such as thoracic, breast, head & neck, genitourinary, gastrointestinal, hematological, and pediatric cancers. Hollings Cancer Center is the largest academic-based cancer program in South Carolina. The Hollings Cancer Center is currently a developing National Cancer Institute designated cancer center and has more than $35M in cancer research funding. More than 1,000 people are currently participating in a cancer clinical trial at HCC. For more information, please visit www.hcc.musc.edu.